JPWO2021079983A1 - - Google Patents
Info
- Publication number
- JPWO2021079983A1 JPWO2021079983A1 JP2021553559A JP2021553559A JPWO2021079983A1 JP WO2021079983 A1 JPWO2021079983 A1 JP WO2021079983A1 JP 2021553559 A JP2021553559 A JP 2021553559A JP 2021553559 A JP2021553559 A JP 2021553559A JP WO2021079983 A1 JPWO2021079983 A1 JP WO2021079983A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019193329 | 2019-10-24 | ||
| PCT/JP2020/039896 WO2021079983A1 (ja) | 2019-10-24 | 2020-10-23 | 軟骨保護用の医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2021079983A1 true JPWO2021079983A1 (ja) | 2021-04-29 |
Family
ID=75619826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021553559A Pending JPWO2021079983A1 (ja) | 2019-10-24 | 2020-10-23 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220401461A1 (ja) |
| EP (1) | EP4049724A4 (ja) |
| JP (1) | JPWO2021079983A1 (ja) |
| KR (1) | KR20220087499A (ja) |
| CN (1) | CN114599370A (ja) |
| WO (1) | WO2021079983A1 (ja) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2152700B1 (en) * | 2007-05-21 | 2013-12-11 | Novartis AG | Csf-1r inhibitors, compositions, and methods of use |
| WO2010011898A1 (en) * | 2008-07-25 | 2010-01-28 | Indiana University Research Technology Corporation | Method for treatment of bone diseases and fractures |
| WO2010038153A1 (en) * | 2008-10-01 | 2010-04-08 | The University Of British Columbia | Use of sox transcription factor acti\ators for stimulating chondrogenesis |
| ES2594556T3 (es) | 2010-07-30 | 2016-12-21 | Daito Chemix Corporation | Derivado de naftaleno |
| EP2623494B1 (en) | 2010-09-30 | 2015-09-02 | Daito Chemix Corporation | Agent for treatment of eye diseases |
| JP6261011B2 (ja) | 2013-02-20 | 2018-01-17 | 国立大学法人京都大学 | 眼疾患処置薬 |
| WO2014207241A1 (en) * | 2013-06-28 | 2014-12-31 | Alzprotect | NEW Na-SUBSTITUTED CARBOLINE COMPOUNDS USABLE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| WO2015033981A1 (ja) | 2013-09-04 | 2015-03-12 | 国立大学法人京都大学 | レプチン抵抗性を改善する医薬組成物 |
| WO2015129809A1 (ja) | 2014-02-28 | 2015-09-03 | 国立大学法人京都大学 | 虚血性眼疾患の処置用の医薬組成物 |
| CN105586389A (zh) * | 2014-10-21 | 2016-05-18 | 天津华大基因科技有限公司 | 试剂盒及其在检测遗传性骨病基因中的用途 |
| PT3733177T (pt) | 2017-12-27 | 2022-09-02 | Univ Kyoto | Composição para proteção da córnea |
| JP2019193329A (ja) | 2018-04-18 | 2019-10-31 | パナソニックＩｐマネジメント株式会社 | 平面モータシステム |
-
2020
- 2020-10-23 WO PCT/JP2020/039896 patent/WO2021079983A1/ja unknown
- 2020-10-23 KR KR1020227016836A patent/KR20220087499A/ko unknown
- 2020-10-23 EP EP20879043.6A patent/EP4049724A4/en not_active Withdrawn
- 2020-10-23 CN CN202080073934.1A patent/CN114599370A/zh active Pending
- 2020-10-23 JP JP2021553559A patent/JPWO2021079983A1/ja active Pending
- 2020-10-23 US US17/770,932 patent/US20220401461A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220087499A (ko) | 2022-06-24 |
| CN114599370A (zh) | 2022-06-07 |
| EP4049724A4 (en) | 2023-05-03 |
| EP4049724A1 (en) | 2022-08-31 |
| WO2021079983A1 (ja) | 2021-04-29 |
| US20220401461A1 (en) | 2022-12-22 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20220628 |